NCT02176291View on ClinicalTrials.gov

Incomplete Response in Late-Life Depression: Getting to Remission With Buprenorphine

PHASE2CompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

August 31, 2014

Primary Completion Date

April 30, 2017

Study Completion Date

February 28, 2018

Conditions
DepressionMajor Depressive Disorder
Interventions
DRUG

Buprenorphine

low-dose buprenorphine (range 0.2 mg/day -- 2.0 mg/day)

DRUG

Placebo

matched placebo

Trial Locations (1)

15213

Western Psychiatric Institute and Clinic, University of Pittsburgh, Pittsburgh

All Listed Sponsors
collaborator

National Institute of Mental Health (NIMH)

NIH

lead

Jordan F. Karp

OTHER

NCT02176291 - Incomplete Response in Late-Life Depression: Getting to Remission With Buprenorphine | Biotech Hunter | Biotech Hunter